Drug Testing Locations - University Place, WA

Drug Testing in University Place, WA

University Place, Washington Statistics

In University Place, WA, Pierce County, opioid overdose deaths increased by 25% from 2020 to 2021.

University Place, located in Pierce County, found that 15% of high school students reported past-month illicit drug use in a 2022 survey.

Pierce County, which includes University Place, had a 30% rise in fentanyl use cases in emergency rooms in 2021.

University Place accounted for approximately 10% of Pierce County's drug-related arrests in 2021.

In 2021, University Place, within Pierce County, saw a decline in methamphetamine cases by 5% compared to the previous year.

The Pierce County Substance Abuse program reported 38% of rehab admissions for University Place residents were for opiates in 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in University Place, WA & Drug Testing Policies

Employers in University Place, WA, implement stringent drug testing policies to maintain a safe and productive work environment. Pre-employment and random drug screenings are common practices among organizations within the city to ensure a drug-free workplace.

Many employers incorporate the guidelines stipulated by the Washington State Department of Labor and Industries to establish and execute their drug testing policies. These measures effectively deter substance abuse and encourage employees to seek help through Employee Assistance Programs (EAPs) if needed.

Furthermore, University Place companies maintain zero-tolerance policies towards drug use, adhering to both state and federal regulations. Employers facilitate workshops and informative sessions for employees to educate them about the risks associated with drug abuse.

Government Efforts with Drug Problems in University Place, WA

The government of University Place, WA, in collaboration with Pierce County authorities, has implemented comprehensive intervention programs to combat the local drug problem. These initiatives include educational campaigns in schools and community centers aimed at raising awareness about the risks of drug abuse.

Local strategies align with state efforts to tackle substance abuse statewide. Support is extended through resources such as the Washington State Department of Social and Health Services, providing counseling and rehabilitation services to those in need. These programs emphasize the importance of rehabilitation and offer numerous resources for individuals struggling with addiction.

Local Drug Busts & News in University Place, WA

University Place, WA, recently experienced heightened law enforcement activity due to an increased focus on tackling drug-related crime. Local police, in coordination with regional task forces, conducted a series of operations targeting illicit drug distribution networks. These efforts reflect the community's determination to address drug-related issues and enhance public safety, with both residents and officials supporting these initiatives.

The latest drug busts in University Place revealed a significant rise in the distribution of controlled substances, driving the community's awareness and encouraging local participation in prevention programs. Residents have become more vigilant, reporting suspicious activities, which aid law enforcement in executing successful operations. The cooperative spirit between the community and police illustrates the proactive measures taken to curb drug-related offenses.

Efforts to combat drug-related crimes in University Place have led to the uncovering of several clandestine operations. These findings emphasize the importance of inter-agency collaboration, where federal, state, and local authorities pool resources to dismantle organized crime groups. Continued diligence in these areas seeks to disrupt the supply chain of drugs, supporting a safer environment for University Place residents.

University Place law enforcement officials have ramped up educational initiatives alongside their crackdown on drug crimes, fostering a preventative approach. By partnering with schools, local organizations, and health professionals, they aim to reduce demand through education and intervention strategies. These initiatives highlight the community's commitment to proactive engagement rather than purely punitive measures.

In reaction to recent drug busts, University Place has strengthened its resolve to build a resilient community. Increased efforts in public outreach and rehabilitation show a dual focus on enforcement and recovery, aiming to reintegrate affected individuals and minimize recidivism. The city's comprehensive approach underscores its dedication to creating a supportive and secure environment for all its residents.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in University Place, WA. Trusted by employers nationwide for accurate results and exceptional service.

Washington DOT/Non DOT Physicals

Washington Vision Tests

Washington Audiograms

Washington Respirator Fit Tests

Washington Lift Tests

Washington Background Checks

Clinical Testing Services

TB Testing in WA

Diabetes Testing in WA

Infectious Disease Testing in WA

Sickle Cell Anemia Testing in WA

Women/Men's Health Testing in WA

Resources & Citations

Stop Overdose WA

Washington Recovery Help Line

Pierce County Human Services

Addiction, Drug, & Alcohol Institute

The Athena Forum

Tacoma-Pierce County Health Department

Sea Mar Community Health Centers

Crisis Connections

Washington State DSHS

Lifeline Connections

Drug Testing Near University Place, WA

Artondale, WA

Shore Acres, WA

Steilacoom, WA

Tacoma, WA

Ruston, WA

Lakewood, WA

Bayview, WA

Fox Island, WA

Wollochet, WA

Fircrest, WA

Frequently Asked Questions

Customer Reviews